Find what you are looking for

nosotros_2
Companion
animals
A member of the family
nosotros_2
Companion
animals
A member of the family

previous arrow
next arrow

Need help?
Questions?
We will be glad to help you

Pragma


Description
  • Angiotensin-Converting Enzyme I inhibitor and aldosterone antagonist.
  • For use in dogs.
  • Bi-grooved palatable tablets.
Formula
  • Each 500 mg tablet contains:
    Benazepril Hydrochloride ……  2.5 mg
    Spironolactone…………………….10 mg
    Excipients q.s. ………….. 500 mg
  • Each 1000 mg tablet contains:
    Benazepril Hydrochloride ………. 5 mg
    Spironolactone ……………. 20 mg
    Excipients q.s.. ………… 1000 mg
  • Each 2000 mg tablet contains
    Benazepril Hydrochloride…….. 10 mg
    Spironolactone ……………. 40 mg
    Excipients q.s. ………… 2000 mg

    • Angiotensin-Converting Enzyme I inhibitor and aldosterone antagonist.
    • For use in dogs.
    • Bi-grooved palatable tablets.
Indications

Angiotensin-Converting Enzyme I inhibitor and aldosterone antagonist.

It is prescribed in dogs for the treatment of congestive heart failure (CHF) caused by atrioventricular valve insufficiency (mitral and/or tricuspid) or by dilated cardiomyopathy.

The association of spironolactone and benazepril is beneficial as both act on the renin-angiotensin-aldosterone system (RAAS) but at different levels along the cascade. Benazepril, by preventing the formation of Angiotensin-Converting Enzyme, produces vasodilation and inhibits aldosterone secretion. Spironolactone, as an antagonist of aldosterone, blocks aldosterone escape and, thus, prevents the appearance of myocardial fibrosis and ventricular arrhythmias.

Package

For 5 kg of body weight: box with 20 palatable tablets of 500 mg.

For 10 kg of body weight: box with 20 palatable tablets of 1000 mg.

For 20 kg of body weight: box 20 palatable tablets of 2000 mg.

Registered in
  • Argentina
  • Colombia
  • Guatemala
  • Paraguay